These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7507901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.
    Garner RE, Childress AM, Human LG, Domer JE.
    Infect Immun; 1990 Aug; 58(8):2613-20. PubMed ID: 2142482
    [Abstract] [Full Text] [Related]

  • 4. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE, Kuruganti U, Czarniecki CW, Chiu HH, Domer JE.
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [Abstract] [Full Text] [Related]

  • 5. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.
    Domer JE, Garner RE, Befidi-Mengue RN.
    Infect Immun; 1989 Mar; 57(3):693-700. PubMed ID: 2917780
    [Abstract] [Full Text] [Related]

  • 6. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
    Mencacci A, Torosantucci A, Spaccapelo R, Romani L, Bistoni F, Cassone A.
    Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
    [Abstract] [Full Text] [Related]

  • 7. Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.
    Carrow EW, Domer JE.
    Infect Immun; 1985 Jul; 49(1):172-81. PubMed ID: 4008047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Candida albicans mannan-specific, delayed hypersensitivity down-regulatory CD8+ cells are genetically restricted effectors and their production requires CD4 and I-A expression.
    Li SP, Lee SI, Wang Y, Domer JE.
    Int Arch Allergy Immunol; 1996 Apr; 109(4):334-43. PubMed ID: 8634517
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunodiagnosis of candida-infections. I. Sensitivity of the antigens.
    Tomsíková A, Sach J, Zavázal V, Masler L, Nováckova D.
    Mycopathologia; 1980 Jul 01; 71(2):103-11. PubMed ID: 6993955
    [Abstract] [Full Text] [Related]

  • 15. The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.
    Viudes A, Lazzell A, Perea S, Kirkpatrick WR, Peman J, Patterson TF, Martinez JP, López-Ribot JL.
    FEMS Microbiol Lett; 2004 Mar 19; 232(2):133-8. PubMed ID: 15033231
    [Abstract] [Full Text] [Related]

  • 16. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M, Belakova J, Horynova M, Krupka M, Novotny J, Sebestova M, Weigl E.
    Med Mycol; 2008 Aug 19; 46(5):411-20. PubMed ID: 18608941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dissection of the anti-Candida albicans mannan immune response using synthetic oligomannosides reveals unique properties of β-1,2 mannotriose protective epitopes.
    Sendid B, Lecointe K, Collot M, Danzé PM, Damiens S, Drucbert AS, Fradin C, Vilcot JP, Grenouillet F, Dubar F, de Ruyck J, Jawhara S, Mallet JM, Poulain D.
    Sci Rep; 2021 May 24; 11(1):10825. PubMed ID: 34031516
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y, Rhew KY.
    Int Immunopharmacol; 2013 Nov 24; 17(3):651-7. PubMed ID: 24007781
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
    Tansho S, Ab S, Mizutani S, Ono Y, Takesako K, Yamaguchi H.
    Microbiol Immunol; 2002 Nov 24; 46(5):307-11. PubMed ID: 12139389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.